(Q51357634)

4 April 2018

title

Unconjugated hyperbilirubinemia is inversely associated with non-alcoholic steatohepatitis (NASH). (English)

1 reference

4 April 2018

bilirubin metabolic disorder

main subject

steatohepatitis

0 references

1 reference

based on heuristic

inferred from title

non-alcoholic steatohepatitis

1 reference

M Hjelkrem

1

1 reference

4 April 2018

A Morales

series ordinal

2

1 reference

4 April 2018

C D Williams

series ordinal

3

1 reference

4 April 2018

S A Harrison

series ordinal

4

1 reference

4 April 2018

language of work or name

English

0 references

publication date

29 April 2012

1 reference

4 April 2018

Alimentary Pharmacology & Therapeutics

published in

1 reference

4 April 2018

volume

35

1 reference

4 April 2018

issue

12

1 reference

4 April 2018

page(s)

1416-1423

1 reference

4 April 2018

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Histopathology of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Pathophysiology of non-alcoholic steatohepatitis and basis for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Biliverdin reductase: a major physiologic cytoprotectant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Bilirubin is an antioxidant of possible physiological importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Antioxidant activities of bile pigments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Heme oxygenase: a novel target for the modulation of the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

High serum bilirubin level is inversely associated with the presence of carotid plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Inverse Relationship Between Serum Bilirubin and Atherosclerosis in Men: A Meta-Analysis of Published Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

''Iatrogenic Gilbert syndrome''--a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Association between serum uric acid level and chronic liver disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Elevated serum uric acid predicts impaired fasting glucose and type 2 diabetes only among Japanese women undergoing health checkups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

The utility of rifampin in diagnosing Gilbert's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Nonalcoholic fatty liver disease during valproate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Biosynthesis of phycobilins. Formation of the chromophore of phytochrome, phycocyanin and phycoerythrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Bilirubin exhibits a novel anti-cancer effect on human adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Bilirubin inhibits tumor cell growth via activation of ERK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

Variants in the UGT1A1 Gene and the Risk of Pediatric Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05114.X

10.1111/J.1365-2036.2012.05114.X

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018